Contents

Search


trovafloxacin (Trovan)

Tradename: Trovan. (trovafloxacin mesylate) Restricted use by FDA, 1999 (hospitals & nursing homes) Indications: - acute bacterial exacerbations of chronic bronchitis - community acquired pneumonia - nosocomial pneumonia - acute sinusitis - complicated intra-abdominal infections - bacterial peritonitis - postoperative infections - gynecologic & pelvic infections - endometritis - parametritis - septic abortion - post-partum infections - prophylaxis of infection associated with elective colorectal surgery, vaginal & abdominal hysterectomy - uncomplicated skin & skin structure infections - complicated skin & skin structure infections - diabetic foot infections - cellulitis - uncomplicated urinary tract infection (cystitis) - chronic bacterial prostatitis - uncomplicated urethral gonorrhea in males & endocervical & rectal gonorrhea in females - Cervicitis - pelvic inflammatory disease (mild to moderate) Dosage: 200-300 mg PO QD. Tabs: 100 & 200 mg. IV form is L-alanyl-L-alanyl derivative alatrofloxacin. Antimicrobial activity: Gram positive - Streptococcus - Streptococcus pneumoniae - Streptococcus pyogenes - Streptococcus agalactiae - Streptococcus viridans - Enterococcus faecalis - Staphylococcus - Staphylococcus aureus - Staphylococcus epidermidis Gram negative - Haemophilus influenzae - Moraxella catarrhalis - Haemophilus parainfluenzae - Mycoplasma pneumonia - Legionella pneumophila - Chlamydia pneumoniae - Escherichia coli - Pseudomonas aeruginosa - Bacteroides fragilis - Klebsiella pneumonia - Prevotella species - Proteus mirabilis - Neisseria gonorrhoeae - Chlamydia trachomatis - Gardnerella vaginalis Anaerobes - Peptostreptococcus species Adverse effects: 1) not common 1-9% - dizziness, lightheadedness, nausea, headache, vomiting, diarrhea, abdominal pain, vaginitis, pruritus, rash 2) uncommon <1% - many, including acute liver failure

Interactions

drug interactions drug adverse effects of fluoroquinolones

Related

alatrofloxacin (Trovan IV)

General

fluoroquinolone

Properties

INHIBITS: DNA gyrase MISC-INFO: elimination route LIVER 1/2life 12-16 HOURS

Database Correlations

PUBCHEM correlations

References

  1. Pfizer package insert
  2. FDA alert 6/99, www.fda.gov